Earnings Miss at Repros – Analyst Blog
Repros Therapeutics Inc. (RPRX) recently reported second quarter 2012 loss of 21 cents per share, wider than the Zacks Consensus Estimate of a loss of 17 cents but narrower than the year-ago loss of 30 cents per share. Lower...
Read More

